# Gilead Sciences

antiviral biologic leader (HIV, hepatitis) that extended into cell therapy through its Kite Pharma division.


Source: https://cn.bioecon.ru/companies/gilead-sciences/
Updated: 2026-07-29

- 国家: United States

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 总部 | 美国加利福尼亚州Foster City | https://www.sec.gov/Archives/edgar/data/882095/000088209526000006/gild-20251231.htm |
| 生产基地 | 加利福尼亚州Foster City、La Verne、El Segundo、Santa Monica；马里兰州Frederick；爱尔兰科克、都柏林；荷兰Hoofddorp；加拿大埃德蒙顿；加利福尼亚州Oceanside | https://www.sec.gov/Archives/edgar/data/882095/000088209526000006/gild-20251231.htm |
| 员工人数 | 截至2025年17,000名员工 | https://s29.q4cdn.com/585078350/files/doc_financials/2024/q2/V2/gild-q224-resource-book-8-august-2024.pdf, https://www.sec.gov/Archives/edgar/data/882095/000088209526000006/gild-20251231.htm |
| 认证 | ISO 15001（科克基地）；TRUE金级认证（Foster City园区、科克基地） [中等置信度] | https://www.gilead.com/responsibility/sustainability/sustainability-focus-areas |
| 产能 | 到2026年潜在产能超过24,000（预计） [中等置信度] | https://s29.q4cdn.com/585078350/files/doc_financials/2024/q2/V2/gild-q224-resource-book-8-august-2024.pdf |

独立来源: s29.q4cdn.com, sec.gov

## 技术

- [抗体偶联药物（ADC）](https://cn.bioecon.ru/technology/antibody-drug-conjugates-adcs/)
- [生物制药与生物医药](https://cn.bioecon.ru/technology/biopharmaceuticals-biomedicines/)